View All

press releases

corporate presentation

See our latest corporate presentation.

view

events

Evercore ISI 2020 Virtual HealthCONx Conference

View Webcast

Novocure 2020 Virtual Research & Development Day

View Replay

Novocure Q3 2020 Earnings Conference Call

View Presentation View Webcast

2020 Wells Fargo Virtual Healthcare Conference

View Webcast

Novocure Q2 2020 Earnings Conference Call

View Presentation View Webcast

Novocure Q1 2020 Earnings Conference Call

View Webcast

Novocure Q4 and FY 2019 Earnings Conference Call

View Webcast

38th Annual J.P. Morgan Healthcare Conference

View Webcast

Evercore ISI 2nd Annual HealthCONx Conference

View Webcast

Novocure Q3 2019 Earnings Conference Call

View Webcast

Baird’s 2019 Global Healthcare Conference

View Webcast

2019 Wells Fargo Securities Healthcare Conference

View Webcast

2019 Wedbush PacGrow Healthcare Conference

View Webcast

Novocure Q2 2019 Earnings Conference Call

View Webcast

Jefferies 2019 Global Healthcare Conference

View Webcast

Novocure Q1 2019 Earnings Conference Call

View Webcast

Oppenheimer’s 29th Annual Healthcare Conference

View webcast

Novocure Q4 and FY 2018 Earnings Conference Call

View Webcast

37th Annual J.P. Morgan Healthcare Conference

View Webcast

annual reports

See our interactive online annual reports.

view
View All

SEC filings

8-K - Current report filing

8-K - Current report filing

4 - Statement of Changes in Beneficial Ownership

8-K - Current report filing

4 - Statement of Changes in Beneficial Ownership

8-K - Current report filing

10-Q - Quarterly Report

10-Q/A - Amended Quarterly Report

10-Q/A - Amended Quarterly Report

4 - Statement of Changes in Beneficial Ownership

4 - Statement of Changes in Beneficial Ownership

4 - Statement of Changes in Beneficial Ownership

4 - Statement of Changes in Beneficial Ownership

4 - Statement of Changes in Beneficial Ownership

4 - Statement of Changes in Beneficial Ownership

4 - Statement of Changes in Beneficial Ownership

4 - Statement of Changes in Beneficial Ownership

4/A - Amended Statement of Changes in Beneficial Ownership

3 - Initial Statement of Beneficial Ownership

3 - Initial Statement of Beneficial Ownership

4 - Statement of Changes in Beneficial Ownership

4 - Statement of Changes in Beneficial Ownership

4 - Statement of Changes in Beneficial Ownership

4 - Statement of Changes in Beneficial Ownership

4 - Statement of Changes in Beneficial Ownership

4 - Statement of Changes in Beneficial Ownership

4 - Statement of Changes in Beneficial Ownership

8-K - Current report filing

8-K - Current report filing

4 - Statement of Changes in Beneficial Ownership

4 - Statement of Changes in Beneficial Ownership

4 - Statement of Changes in Beneficial Ownership

4 - Statement of Changes in Beneficial Ownership

4 - Statement of Changes in Beneficial Ownership

4 - Statement of Changes in Beneficial Ownership

4 - Statement of Changes in Beneficial Ownership

8-K - Current report filing

10-Q - Quarterly Report

4 - Statement of Changes in Beneficial Ownership

4 - Statement of Changes in Beneficial Ownership

8-K - Current report filing

SC 13G/A - Amended Statement of Ownership

4 - Statement of Changes in Beneficial Ownership

4 - Statement of Changes in Beneficial Ownership

4 - Statement of Changes in Beneficial Ownership

4 - Statement of Changes in Beneficial Ownership

4 - Statement of Changes in Beneficial Ownership

4 - Statement of Changes in Beneficial Ownership

4 - Statement of Changes in Beneficial Ownership

4 - Statement of Changes in Beneficial Ownership

4 - Statement of Changes in Beneficial Ownership

4 - Statement of Changes in Beneficial Ownership

4 - Statement of Changes in Beneficial Ownership

8-K - Current report filing

4 - Statement of Changes in Beneficial Ownership

8-K - Current report filing

4 - Statement of Changes in Beneficial Ownership

4 - Statement of Changes in Beneficial Ownership

4 - Statement of Changes in Beneficial Ownership

4 - Statement of Changes in Beneficial Ownership

3 - Initial Statement of Beneficial Ownership

4 - Statement of Changes in Beneficial Ownership

4 - Statement of Changes in Beneficial Ownership

4 - Statement of Changes in Beneficial Ownership

4 - Statement of Changes in Beneficial Ownership

8-K - Current report filing

10-Q - Quarterly Report

DEFA14A - Additional Proxy Soliciting Materials (definitive)

DEF 14A - Proxy Statement (definitive)

8-K - Current report filing

4 - Statement of Changes in Beneficial Ownership

4 - Statement of Changes in Beneficial Ownership

4 - Statement of Changes in Beneficial Ownership

4 - Statement of Changes in Beneficial Ownership

4 - Statement of Changes in Beneficial Ownership

4 - Statement of Changes in Beneficial Ownership

4 - Statement of Changes in Beneficial Ownership

8-K - Current report filing

4 - Statement of Changes in Beneficial Ownership

4 - Statement of Changes in Beneficial Ownership

4 - Statement of Changes in Beneficial Ownership

4 - Statement of Changes in Beneficial Ownership

4 - Statement of Changes in Beneficial Ownership

4 - Statement of Changes in Beneficial Ownership

S-8 - Securities Registration: Employee Benefit Plan

4 - Statement of Changes in Beneficial Ownership

4 - Statement of Changes in Beneficial Ownership

4 - Statement of Changes in Beneficial Ownership

4 - Statement of Changes in Beneficial Ownership

4 - Statement of Changes in Beneficial Ownership

4 - Statement of Changes in Beneficial Ownership

4 - Statement of Changes in Beneficial Ownership

10-K - Annual Report

8-K - Current report filing

4 - Statement of Changes in Beneficial Ownership

4 - Statement of Changes in Beneficial Ownership

4 - Statement of Changes in Beneficial Ownership

4 - Statement of Changes in Beneficial Ownership

4 - Statement of Changes in Beneficial Ownership

SC 13G - Statement of Ownership

stock information

See our current stock performance, trading data and historical pricing information (NASDAQ: NVCR).

Learn More

corporate governance

See our corporate governance documents.

Learn More

FAQs

What is the ticker symbol for Novocure?

Shares of Novocure are traded on the NASDAQ Global Select Stock Market under the ticker symbol NVCR.

When did Novocure go public?

Novocure started trading publicly on October 2, 2015.

Where is Novocure's corporate headquarters?

Novocure is headquartered in the Bailiwick of Jersey.

When does Novocure's fiscal year end?

December 31.

Who is Novocure's transfer agent?

Our transfer agent is Computershare Shareowner Services LLC. There are a number of ways to contact Computershare to access information in connection with your account. Note: you will need to supply your tax identification number and contact information, including address.

Investor Centre™ website:

Manage your account online via Computershare’s secure Web-based shareholder tool at http://www.computershare.com/investor. Through free, around-the-clock access to the website, you can:

  • View your account details and update account information
  • Access tax forms
  • Request certificates
  • Enroll in eDelivery to receive shareholder materials electronically

Telephone inquiries:
+1 (877) 373-6374 (US, Canada, Puerto Rico)
+1 (781) 575-3100 (non-US)

Written requests:
By regular mail:
Computershare
P.O. Box 43070
Providence, RI 02940-3070

By overnight delivery:
Computershare
250 Royall Street
Canton, MA 02021

How do I change the address on my stockholder account?

If you own shares through a brokerage firm, you need to contact that firm directly to change your account address.

If you own shares in the form of a stock certificate, you may update your address by contacting our transfer agent, Computershare Shareowner Services LLC, at 877-419-8459 or via their website at https://www-us.computershare.com/investor.

How can I buy Novocure stock?

Shares can be purchased through a stockbroker of your choice. Novocure does not have a direct stock purchase program.

What is Novocure's CUSIP number?

Our ordinary shares CUSIP number is G6674U 108.

Who are the independent auditors?

Kost Forer Gabbay & Kasierer
A member of Ernst & Young Global
Tel-Aviv, Israel